Investigate the effect of botulinum toxin type A (BTX-A) on nasal symptoms inpatients with allergic rhinitis.
Unal
Murat
M
D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007552:Isotonic Solutions / Q000494:pharmacology / Q000627:therapeutic use; D009079:Mucociliary Clearance / Q000187:drug effects; D009465:Neuromuscular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D000077331:Ringer's Solution
D007552:Isotonic Solutions; D009465:Neuromuscular Agents; D000077331:Ringer's Solution; D019274:Botulinum Toxins, Type A